Literature DB >> 20536383

Impaired turnover of autophagolysosomes in cathepsin L deficiency.

Julia Dennemärker1, Tobias Lohmüller, Sebastian Müller, Stephanie Vargas Aguilar, Desmond J Tobin, Christoph Peters, Thomas Reinheckel.   

Abstract

Some of the phenotypes of mice deficient for the lysosomal cysteine endopeptidase cathepsin L (Ctsl) are characterized by large dysmorphic vesicles in the cytoplasm. Specifically, the heart (dilative cardiomyopathy), the thyroid (impaired thyroglobulin processing) and keratinocytes (periodic hair loss and epidermal hyperproliferation) are affected. We hypothesized that the formation of aberrant vesicles is owing to defects in macroautophagy. Therefore, primary mouse embryonic fibroblasts (MEF), which were derived from Ctsl(-/-) animals crossed with mice transgenic for the autophagy marker GFP-LC3, were investigated. Ctsl(-/-) MEF show increased number and size of vesicular structures belonging to the 'acidic' cellular compartment and are also characterized by GFP-LC3. Induction of autophagy by nutrient starvation or rapamycin treatment showed no significant impairment of the initiation of autophagy, the formation of autophagosomes or autophagosome-lysosome fusion in Ctsl(-/-) MEF, but co-localization of GFP-LC3 and Lamp1 revealed unusually large autophagolysosomes filled with Lamp1. Furthermore, the soluble lysosomal enzyme cathepsin D was elevated in Ctsl(-/-) MEF. Thus, degradation of autophagolysosomal content is impaired in the absence of Ctsl. This could slow the turnover of autophagolysosomes and result in accumulation of the dysmorphic and 'acidic' vesicles that were previously described in the context of the pathological phenotypes of Ctsl(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20536383     DOI: 10.1515/BC.2010.097

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  35 in total

1.  On how mammary gland reprogramming metalloproteinases couple form with function.

Authors:  Bonnie F Sloane
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-07-01       Impact factor: 10.005

Review 2.  Specialized roles for cysteine cathepsins in health and disease.

Authors:  Jochen Reiser; Brian Adair; Thomas Reinheckel
Journal:  J Clin Invest       Date:  2010-10-01       Impact factor: 14.808

Review 3.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

Review 4.  The role of autophagy in cardiac hypertrophy.

Authors:  Lanfang Li; Jin Xu; Lu He; Lijun Peng; Qiaoqing Zhong; Linxi Chen; Zhisheng Jiang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-04-15       Impact factor: 3.848

5.  Deletion of cysteine cathepsins B or L yields differential impacts on murine skin proteome and degradome.

Authors:  Stefan Tholen; Martin L Biniossek; Martina Gansz; Alejandro Gomez-Auli; Fee Bengsch; Agnes Noel; Jayachandran N Kizhakkedathu; Melanie Boerries; Hauke Busch; Thomas Reinheckel; Oliver Schilling
Journal:  Mol Cell Proteomics       Date:  2012-12-10       Impact factor: 5.911

Review 6.  Tuning flux: autophagy as a target of heart disease therapy.

Authors:  Min Xie; Cyndi R Morales; Sergio Lavandero; Joseph A Hill
Journal:  Curr Opin Cardiol       Date:  2011-05       Impact factor: 2.161

Review 7.  Functions of autophagy in hepatic and pancreatic physiology and disease.

Authors:  Mark J Czaja
Journal:  Gastroenterology       Date:  2011-04-23       Impact factor: 22.682

Review 8.  Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.

Authors:  Oakley C Olson; Johanna A Joyce
Journal:  Nat Rev Cancer       Date:  2015-12       Impact factor: 60.716

Review 9.  Autophagy and pancreatitis.

Authors:  Anna S Gukovskaya; Ilya Gukovsky
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-09-06       Impact factor: 4.052

10.  Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis.

Authors:  Stefan Tholen; Martin L Biniossek; Martina Gansz; Theresa D Ahrens; Manuel Schlimpert; Jayachandran N Kizhakkedathu; Thomas Reinheckel; Oliver Schilling
Journal:  Cell Mol Life Sci       Date:  2013-06-29       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.